Methods for deriving risk difference (absolute risk reduction) from a meta-analysis

BMJ. 2023 May 5:381:e073141. doi: 10.1136/bmj-2022-073141.

Authors

M Hassan Murad¹, Zhen Wang¹, Ye Zhu¹, Samer Saadi¹, Haitao Chu^{2

3}, Lifeng Lin⁴

Affiliations

¹ Evidence-based Practice Center, Mayo Clinic, Rochester, MN 55905, USA.
² Division of Biostatistics, University of Minnesota, Minneapolis, MN, USA.
³ Statistical Research and Data Science Center, New York, NY, USA.
⁴ ‪Department of Epidemiology and Biostatistics, University of Arizona, Tucson, AZ, USA‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬‬.

PMID: 37146999
DOI: 10.1136/bmj-2022-073141

No abstract available

Publication types

Meta-Analysis

MeSH terms

Antirheumatic Agents* / therapeutic use
Arthritis, Rheumatoid* / drug therapy
Humans
Meta-Analysis as Topic
Numbers Needed To Treat

Substances

Antirheumatic Agents